|
Category: solvents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 67.50 °C. @ 760.00 mm Hg
|
| Boiling Point: | 315.00 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | > 230.00 °F. TCC ( > 110.00 °C. )
|
| logP (o/w): | 0.700 |
| Soluble in: |
| | water, 1.583e+004 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-mammal (species unspecified) LD50 > 5000 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 39(4), Pg. 86, 1974.
intraperitoneal-mouse LD50 1240 mg/kg PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: MUSCLE WEAKNESS Journal of Pharmacology and Experimental Therapeutics. Vol. 93, Pg. 470, 1948.
oral-mouse LD50 2650 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 8, Pg. 477, 1949.
oral-rat LD > 500 mg/kg National Academy of Sciences, National Research Council, Chemical-Biological Coordination Center, Review. Vol. 5, Pg. 16, 1953.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 920 mg/kg AUTONOMIC NERVOUS SYSTEM: "SMOOTH MUSCLE RELAXANT (MECHANISM UNDEFINED, SPASMOLYTIC)" Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 1355, 1965.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | solvents |
| Recommendation for phenoxypropanediol usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for phenoxypropanediol flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | antodyn | | | antodyne | | 1,2- | dihydroxy-3-phenoxypropane | | | phenol glycerol ether | | | phenol glyceryl ether | | 3- | phenoxy-1,2-propane diol | | 3- | phenoxy-1,2-propanediol | | 3- | phenoxypropane-1,2-diol | | | phenyl glycerol | | | phenyl glyceryl ether | | a- | phenyl monoglyceryl ether | | 1- | phenylglycerol | | | phenylglyceryl ether | | 1,2- | propanediol, 3-phenoxy- |
Articles:
|